
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 27, 2023, titled "Dr. Reddy's Laboratories announces the launch of Difluprednate Ophthalmic Emulsion 0.05% in the U.S. Market.".
Filed with NSE ·
Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call · Replay · Jul 22Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 27, 2023, titled "Dr. Reddy's Laboratories announces the launch of Difluprednate Ophthalmic Emulsion 0.05% in the U.S. Market.".
6ix hasn’t read this filing yet.
Dr. Reddy's Laboratories Ltd. on 6ix
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories